PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 14, 2026Neuro-Oncology Advances1 citationsOpen Access

GlioMODA: Robust Glioma Segmentation in Clinical Routine

View Full Paper
JCJulian CanisiusKlinikum rechts der IsarJBJosef A. BuchnerKlinikum rechts der IsarMRMarcel RosierHelmholtz Zentrum München

Key Points

  • Evaluate GlioMODA, a deep learning framework for glioma segmentation in routine clinical MRI protocols.
  • Trained and validated on the BraTS 2021 dataset with 1,251 training and 219 testing cases.
  • Assessed performance across eleven MRI protocol combinations.
  • Evaluated segmentation accuracy using Dice similarity coefficients and volumetric accuracy against manual ground truth.
  • Achieved state-of-the-art segmentation accuracy across tumor subregions.
  • Maintained robust performance with incomplete MRI protocols.
  • Demonstrated minimal volumetric differences for enhancing tumor and whole tumor, with statistical significance confirmed.

Abstract

Abstract Background Precise glioma segmentation in MRI is essential for accurate diagnosis, optimal treatment planning, and advancing clinical research. However, most deep learning approaches require complete, standardized MRI protocols that are frequently unavailable in routine clinical practice. This study presents and evaluates GlioMODA, a robust deep learning framework designed for automated glioma segmentation that delivers consistent high performance across varied and incomplete MRI protocols. Methods GlioMODA was trained and validated on the BraTS 2021 dataset (1,251 training, 219 testing cases), systematically assessing performance across eleven clinically relevant MRI protocol combinations. Segmentation accuracy was evaluated using Dice similarity coefficients (DSC) and panoptic quality metrics. Volumetric accuracy was benchmarked against manual ground truth, and statistical significance was established via Wilcoxon signed‑rank tests with Benjamini–Yekutieli correction. Results GlioMODA demonstrated state-of-the-art segmentation accuracy across tumor subregions, maintaining robust performance with incomplete or heterogeneous MRI protocols. Protocols including both T1-weighted contrast-enhanced and T2-FLAIR sequences yielded volumetric differences versus manual ground truth that were not statistically significant for enhancing tumor (ET: median difference 55 mm³, p = 0.157) and whole tumor (WT: median difference –7 mm³, p = 1.0), and exhibited median DSC differences close to zero relative to the four‑sequence reference protocol. Omitting either sequence led to substantial and significant volumetric errors. Conclusions GlioMODA facilitates reliable, automated glioma segmentation using a streamlined two‑sequence protocol (T1‑contrast + T2‑FLAIR), supporting clinical workflow optimization and broader implementation of quantitative volumetry compatible with RANO 2.0 criteria. GlioMODA is published as an open-source, easy-to-use Python package at https://github.com/BrainLesion/GlioMODA/.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Canisius et al. (2026) studied this question.

synapsesocial.com/papers/699011602ccff479cfe58001https://doi.org/10.1093/noajnl/vdag034
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Enhancing efficiency in pediatric brain tumor segmentation using a pathologically diverse single-center clinical dataset2026 · 2 citations
  2. 2Modality redundancy for MRI-based glioblastoma segmentation2024 · 14 citations
  3. 3Matplotlib: A 2D Graphics Environment2007 · 40,924 citations
  4. 4MRI contrast agents: Basic chemistry and safety2012 · 334 citations
  5. 5CheckList for EvaluAtion of Radiomics research (CLEAR): a step-by-step reporting guideline for authors and reviewers endorsed by ESR and EuSoMII2023 · 453 citations